Independent forecasts built on public federal data. Not a U.S. government website.

MED SURGE - OMNIPODS for Multiple CMOPS 760, 761, and 766A

36C77025Q0049 · VETERANS AFFAIRS, DEPARTMENT OF

A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, with responses due 2024-11-25. AwardCast estimates what this specific solicitation will close for, before you bid.

36C77025Q0049
solicitation
325413
NAICS
6515
PSC
Not set aside
set-aside
2024-11-25
responses due

What's being bought

RFQ - 36C77025Q0049 JnA - 36C77025Q0049 Pricing Schedule - Excel - 36C77025Q0049

Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

WinnerAward valueOffersDate
REMEL INC.$64Kn/a2026-07-02
CEPHEID$306Kn/a2026-07-01
ABBOTT LABORATORIES INC.$2.8Mn/a2026-07-01
BECTON, DICKINSON AND COMPANY$21K12026-07-01
ABBOTT LABORATORIES INC.$102K12026-07-01

Questions

What is solicitation 36C77025Q0049?

MED SURGE - OMNIPODS for Multiple CMOPS 760, 761, and 766A, issued by VETERANS AFFAIRS, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING). Responses are due 2024-11-25.

What do similar contracts close for?

Comparable closed awards in this category ran from $21K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.

Explore the market

Comparable awards in this market ran from $21K to $2.8M. Get the full set by email.

Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.

Every forecast is scored against the real award once it becomes public. See the track record.

Closed awards from public federal data, not the forecast. One email, no account.

Or get the forecast for this solicitation — $49, one report.